What PALL CORP's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Chandy Ruby R | President, Pall Industrial | Aug 31 | Disposition to Issuer · D | −7,551 | $127.20 | −$960K | 0 |
| Chandy Ruby R | President, Pall Industrial | Aug 31 | Disposition to Issuer · D | −2,231 | $127.20 | −$284K | 0 |
| Chandy Ruby R | President, Pall Industrial | Aug 31 | Disposition to Issuer · D | −15,289 | — | — | 0 |
| Egholm Michael | President, BioPharmaceuticals | Aug 31 | Disposition to Issuer · D | −19,399 | $127.20 | −$2.47M | 0 |
| Egholm Michael | President, BioPharmaceuticals | Aug 31 | Disposition to Issuer · D | −12,822 | — | — | 0 |
| Egholm Michael | President, BioPharmaceuticals | Aug 31 | Disposition to Issuer · D | −9,201 | $127.20 | −$1.17M | 0 |
| Coutts Robert B | Director | Aug 31 | Disposition to Issuer · D | −16,872 | $127.20 | −$2.15M | 0 |
| Owens B Craig | Director | Aug 31 | Disposition to Issuer · D | −4,988 | $127.20 | −$634K | 0 |
| Owens B Craig | Director | Aug 31 | Disposition to Issuer · D | −7,000 | $127.20 | −$890K | 0 |
| Kingsley Lawrence D | Chairman, President and CEO | Aug 31 | Disposition to Issuer · D | −86,735 | $127.20 | −$11M | 0 |
| Kingsley Lawrence D | Chairman, President and CEO | Aug 31 | Disposition to Issuer · D | −111,764 | — | — | 0 |
| Kingsley Lawrence D | Chairman, President and CEO | Aug 31 | Disposition to Issuer · D | −189,364 | $127.20 | −$24.1M | 0 |
| Grise Cheryl W | Director | Aug 31 | Disposition to Issuer · D | −1,000 | $127.20 | −$127K | 0 |
| Grise Cheryl W | Director | Aug 31 | Disposition to Issuer · D | −21,128 | $127.20 | −$2.69M | 0 |
| Alving Amy E | Director | Aug 31 | Disposition to Issuer · D | −6,433 | $127.20 | −$818K | 0 |
| Alving Amy E | Director | Aug 31 | Disposition to Issuer · D | −5,840 | $127.20 | −$743K | 0 |
| Behnia Roya | SVP, Gen. Counsel & Corp. Sec. | Aug 31 | Disposition to Issuer · D | −10,950 | — | — | 0 |
| Behnia Roya | SVP, Gen. Counsel & Corp. Sec. | Aug 31 | Disposition to Issuer · D | −3,469 | $127.20 | −$441K | 0 |
| Camarco Kenneth V | SVP Global Ops & Business Sys. | Aug 31 | Disposition to Issuer · D | −7,303 | $127.20 | −$929K | 0 |
| Camarco Kenneth V | SVP Global Ops & Business Sys. | Aug 31 | Disposition to Issuer · D | −16,451 | — | — | 0 |
Loading...
